These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2306682)
1. An analysis of immunocomplexes for the detection of the early stages of colon cancer. Chester SJ; Maimonis P; Meitner PA; Vezeridis MP Cancer; 1990 Mar; 65(6):1338-44. PubMed ID: 2306682 [TBL] [Abstract][Full Text] [Related]
2. Improved detection of the early stages of colon cancer by determining both free circulating and immune complex-bound antigens reactive with monoclonal antibody. Chester SJ; Lim YP; Vezeridis MP; Hixson DC Cancer Res; 1994 Aug; 54(15):3974-8. PubMed ID: 8033125 [TBL] [Abstract][Full Text] [Related]
3. A new radioimmunoassay detecting early stages of colon cancer: a comparison with CEA, AFP, and Ca 19-9. Chester SJ; Maimonis P; Vanzuiden P; Finklestein M; Bookout J; Vezeridis MP Dis Markers; 1991; 9(5):265-71. PubMed ID: 1724634 [TBL] [Abstract][Full Text] [Related]
4. A clinical study of CA-50 as a tumour marker for monitoring of colorectal cancer. Persson BE; Ståhle E; Påhlman L; Glimelius B; Nilsson O; Lindholm L; Norrgård-Pedersen B; Holmgren J Med Oncol Tumor Pharmacother; 1988; 5(3):165-71. PubMed ID: 3166084 [TBL] [Abstract][Full Text] [Related]
5. [Carcinoembryonic antigen in serum and the tissue of patients with colon cancer]. Odagiri E; Jibiki K; Shinozaki H; Nakamura S; Demura R; Demura H; Suzuki H Gan No Rinsho; 1984 Oct; 30(13):1680-5. PubMed ID: 6513021 [TBL] [Abstract][Full Text] [Related]
6. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Foon KA; John WJ; Chakraborty M; Das R; Teitelbaum A; Garrison J; Kashala O; Chatterjee SK; Bhattacharya-Chatterjee M J Clin Oncol; 1999 Sep; 17(9):2889-5. PubMed ID: 10561367 [TBL] [Abstract][Full Text] [Related]
8. The detection of colorectal carcinomas with the use of CA-50 radioimmunoassay inhibition test. Habib NA; Hershman MJ; Papp L; Swift I; Williamson RC; Wood CB Int J Colorectal Dis; 1986 Jul; 1(3):186-7. PubMed ID: 3475393 [TBL] [Abstract][Full Text] [Related]
9. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging. Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251 [TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518 [TBL] [Abstract][Full Text] [Related]
11. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427 [TBL] [Abstract][Full Text] [Related]
15. [Cell balance between apoptosis and proliferation in colon cancer and its correlation with prognosis]. Chen JM; Li WH; Wang JD; Feng YD; Wu JH; Gong JP Ai Zheng; 2005 May; 24(5):554-8. PubMed ID: 15890096 [TBL] [Abstract][Full Text] [Related]
16. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Petersen VC; Baxter KJ; Love SB; Shepherd NA Gut; 2002 Jul; 51(1):65-9. PubMed ID: 12077094 [TBL] [Abstract][Full Text] [Related]
17. DNA in situ sensitivity to denaturation: a new parameter for flow cytometry of normal human colonic epithelium and colon carcinoma. Kunicka JE; Darzynkiewicz Z; Melamed MR Cancer Res; 1987 Aug; 47(15):3942-7. PubMed ID: 3607742 [TBL] [Abstract][Full Text] [Related]
18. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer. Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of investigations for colorectal carcinoma in symptomatic patients. Kalra L; Hamlyn AN Postgrad Med J; 1988 Sep; 64(755):666-8. PubMed ID: 3251216 [TBL] [Abstract][Full Text] [Related]
20. Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Korsgaard M; Pedersen L; Sørensen HT; Laurberg S Cancer Detect Prev; 2006; 30(4):341-6. PubMed ID: 16965875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]